Syra Health Corp.
SYRA
$0.10
-$0.0069-6.46%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.42% | -10.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.42% | -10.94% | |||
| Cost of Revenue | -18.23% | -2.12% | |||
| Gross Profit | 29.38% | -31.86% | |||
| SG&A Expenses | 6.66% | -7.90% | |||
| Depreciation & Amortization | -6.85% | -71.37% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.07% | -6.48% | |||
| Operating Income | 5.66% | -16.97% | |||
| Income Before Tax | 6.36% | -20.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.36% | -20.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.36% | -20.81% | |||
| EBIT | 5.66% | -16.97% | |||
| EBITDA | 5.64% | -22.56% | |||
| EPS Basic | 20.47% | 10.78% | |||
| Normalized Basic EPS | 20.31% | 10.86% | |||
| EPS Diluted | 20.47% | 10.78% | |||
| Normalized Diluted EPS | 20.31% | 10.86% | |||
| Average Basic Shares Outstanding | 17.77% | 35.43% | |||
| Average Diluted Shares Outstanding | 17.77% | 35.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||